Literature DB >> 10463685

Early, intermediate, and late acute stages in Chagas' disease: a study combining anti-galactose IgG, specific serodiagnosis, and polymerase chain reaction analysis.

P R Antas1, N Medrano-Mercado, F Torrico, R Ugarte-Fernandez, F Gómez, R Correa Oliveira, A C Chaves, A J Romanha, T C Araújo-Jorge.   

Abstract

The acute phase of Chagas' disease was classified as early, intermediate, and late based on the levels of anti-Galalpha, 3Gal IgG (Gal) and specific IgM (M) and IgG (G) anti-T. cruzi reactivity. While the early phase was M+G-Gal-, the intermediate phase was M+G-Gal+, M+G+Gal-, or M+G+Gal+, and the late phase was M-G+Gal+. This sequence of stages was consistent with our previous studies on acute-phase proteins. Analysis by the polymerase chain reaction (PCR) of parasite DNA in 65 blood samples of children living in Cochabamba, Bolivia showed a significant correlation (90.8%) between ELISA and PCR positivity. A lower correlation was observed between indirect hemagglutination, PCR (58%), and ELISA. Electrocardiographic analysis of 43 children studied by the PCR did not show any alteration typical of acute chagasic myocarditis. The PCR positivity was observed in eight samples where only Gal was increased, suggesting a very early T. cruzi infection, when specific antibodies were not yet present. By associating anti-Gal IgG with specific serology, early T. cruzi infection can be detected with greater precision. We suggest the use of anti-Gal antibody reactivity as an aid for the detection of recent T. cruzi infections, at least in endemic areas where diseases caused by other trypanosomatids do not overlap.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10463685     DOI: 10.4269/ajtmh.1999.61.308

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  12 in total

1.  Clinical aspects of Chagas disease and implications for novel therapies.

Authors:  Cristiane Menezes; Germano Carneiro Costa; Kenneth J Gollob; Walderez O Dutra
Journal:  Drug Dev Res       Date:  2011-09       Impact factor: 4.360

2.  Polymerase chain reaction detection of Trypanosoma cruzi in Macaca fascicularis using archived tissues.

Authors:  Jeff T Williams; James N Mubiru; Natalia E Schlabritz-Loutsevitch; Rohina C Rubicz; John L VandeBerg; Edward J Dick; Gene B Hubbard
Journal:  Am J Trop Med Hyg       Date:  2009-08       Impact factor: 2.345

Review 3.  Current concepts in immunoregulation and pathology of human Chagas disease.

Authors:  Walderez O Dutra; Kenneth J Gollob
Journal:  Curr Opin Infect Dis       Date:  2008-06       Impact factor: 4.915

4.  Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.

Authors:  Ernesto S Nakayasu; Tiago J P Sobreira; Rafael Torres; Luciane Ganiko; Paulo S L Oliveira; Alexandre F Marques; Igor C Almeida
Journal:  J Proteome Res       Date:  2011-12-08       Impact factor: 4.466

Review 5.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

Review 6.  Current understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas disease.

Authors:  Fabiana S Machado; Walderez O Dutra; Lisia Esper; Kenneth J Gollob; Mauro M Teixeira; Stephen M Factor; Louis M Weiss; Fnu Nagajyothi; Herbert B Tanowitz; Nisha J Garg
Journal:  Semin Immunopathol       Date:  2012-10-18       Impact factor: 9.623

7.  PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy.

Authors:  Lúcia M C Galvão; Egler Chiari; Andréa M Macedo; Alejandro O Luquetti; Simonne A Silva; Ana Lúcia S S Andrade
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

8.  Orally-transmitted Chagas disease: Epidemiological, clinical, serological and molecular outcomes of a school microepidemic in Chichiriviche de la Costa, Venezuela.

Authors:  Belkisyolé Alarcón de Noya; Cecilia Colmenares; Zoraida Díaz-Bello; Raiza Ruiz-Guevara; Karen Medina; Arturo Muñoz-Calderón; Luciano Mauriello; Elida Cabrera; Luís Montiel; Sandra Losada; Jetzi Martínez; Raúl Espinosa; Teresa Abate
Journal:  Parasite Epidemiol Control       Date:  2016-02-27

9.  Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.

Authors:  Shivali Gupta; Xianxiu Wan; Maria P Zago; Valena C Martinez Sellers; Trevor S Silva; Dadjah Assiah; Monisha Dhiman; Sonia Nuñez; John R Petersen; Juan C Vázquez-Chagoyán; Jose G Estrada-Franco; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

Review 10.  Acute chagas disease: new global challenges for an old neglected disease.

Authors:  Daniela V Andrade; Kenneth J Gollob; Walderez O Dutra
Journal:  PLoS Negl Trop Dis       Date:  2014-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.